Clinically established biodegradable long acting injectables: An industry perspective

Advanced Drug Delivery Reviews, vol. 167, pp. 19–46

Authors 12

1. Christian Isalomboto Nkanga

   Novartis (Switzerland) · Rhodes University · University of Kinshasa

   Affiliation as printed

   Center for Chemico- and Bio-Medicinal Research (CCBR), Department of Chemistry, Rhodes University, P.O. Box 94, Grahamstown 6140, South Africa; Faculty of Pharmaceutical Sciences, University of Kinshasa, B.P. 212, Kinshasa, XI, Democratic Republic of the Congo; Technical Research and Development, Novartis Pharma AG, Basel 4002, Switzerland

   Center for Chemico- and Bio-Medicinal Research (CCBR), Department of Chemistry, Rhodes University, P.O. Box 94, Grahamstown 6140, South Africa

   Faculty of Pharmaceutical Sciences, University of Kinshasa, B.P. 212, Kinshasa, XI, Democratic Republic of the Congo

   Technical Research and Development, Novartis Pharma AG, Basel 4002, Switzerland

2. Andreas Fisch

   Novartis (Switzerland)

   Affiliation as printed

   Technical Research and Development, Novartis Pharma AG, Basel 4002, Switzerland

3. Mazda Rad‐Malekshahi

   Tehran University of Medical Sciences

   Affiliation as printed

   Department of Pharmaceutical Biomaterials and Medical Biomaterials Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

4. Marieta Duvnjak Romić

   Novartis (Switzerland)

   Affiliation as printed

   Technical Research and Development, Novartis Pharma AG, Basel 4002, Switzerland

5. Birgit Kittel

   Novartis (Switzerland) · Novartis Institutes for BioMedical Research

   Affiliation as printed

   Novartis Institute for Biomedical Research, Novartis Pharma AG, Basel 4002, Switzerland

6. Thomas Ullrich

   Novartis (Switzerland) · Novartis Institutes for BioMedical Research

   Affiliation as printed

   Novartis Institute for Biomedical Research, Novartis Pharma AG, Basel 4002, Switzerland

7. Jing Wang

   Novartis (Switzerland)

   Affiliation as printed

   Technical Research and Development, Novartis Pharma AG, Basel 4002, Switzerland

8. Rui W. M. Krause

   Rhodes University

   Affiliation as printed

   Center for Chemico- and Bio-Medicinal Research (CCBR), Department of Chemistry, Rhodes University, P.O. Box 94, Grahamstown 6140, South Africa

9. Sabine Adler

   Novartis (Switzerland)

   Affiliation as printed

   Technical Research and Development, Novartis Pharma AG, Basel 4002, Switzerland

10. Twan Lammers Aachen Department of Experimental Molecular Imaging

    RWTH Aachen University

    Affiliation as printed

    Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany

11. Wim E. Hennink

    Utrecht University

    Affiliation as printed

    Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, the Netherlands

12. Farshad Ramazani corresponding

    Novartis (Switzerland)

    Affiliation as printed

    Technical Research and Development, Novartis Pharma AG, Basel 4002, Switzerland. Electronic address: farshad.ramazani@novartis.com

    Technical Research and Development, Novartis Pharma AG, Basel 4002, Switzerland